FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie Inc. This action represents an approved supplement to the product's regu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Migraine

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

SUPPL AP for DEPAKOTE ER (DIVALPROEX SODIUM)